Cargando…

Real-World Prescription Patterns For Patients With Young-Onset Parkinson’s Disease in China: A Trend Analysis From 2014 to 2019

Introduction Pharmacotherapy is one of the main treatments for patients with young-onset Parkinson’s disease (YOPD). Although numerous studies on the treatment of YOPD have been published, the real-world prescription patterns of these populations remain unclear in China. Methods A national comprehen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiao-qin, Wang, Xiao-yu, Shen, Hui-ming, Pang, Wen-yuan, Zhong, Ming-kang, Ma, Chun-lai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133339/ https://www.ncbi.nlm.nih.gov/pubmed/35645835 http://dx.doi.org/10.3389/fphar.2022.858139

Ejemplares similares

Erratum: Real-World Prescription Patterns For Patients With Young-Onset Parkinson’s Disease in China: A Trend Analysis From 2014 to 2019
por: Frontiers Production Office,
Publicado: (2022)

Real-world prescription patterns for reproductive assistance patients in China: A trend analysis from 2016 to 2020
por: Jin, Jing, et al.
Publicado: (2022)

Trends in Topical Prescriptional Therapy for Old Patients With Dry Eye Disease in Six Major Areas of China: 2013–2019
por: Yu, Zhenwei, et al.
Publicado: (2021)

Greater than the Sum: Applying Daily-Dose Equivalents to Antipsychotic Prescription Claims to Study Real-World Effects
por: Hayes, Kaleen N., et al.
Publicado: (2021)

Cardiotoxicity Induced by Immune Checkpoint Inhibitors: A Pharmacovigilance Study From 2014 to 2019 Based on FAERS
por: Chen, Chenxin, et al.
Publicado: (2021)

Real-world efficacy and safety of pyrotinib in patients with HER2-positive metastatic breast cancer: A prospective real-world study
por: Zhang, Qiongwen, et al.
Publicado: (2023)

Estimating Adherence Based on Prescription or Dispensation Information: Impact on Thresholds and Outcomes. A Real-World Study With Atrial Fibrillation Patients Treated With Oral Anticoagulants in Spain
por: Hurtado-Navarro, Isabel, et al.
Publicado: (2018)

Parkinson’s disease, dopaminergic drugs and the plant world
por: Kempster, Peter, et al.
Publicado: (2022)

Trends in Anticoagulation Prescription Spending Among Medicare Part D and Medicaid Beneficiaries Between 2014 and 2019
por: Duvalyan, Angela, et al.
Publicado: (2021)

Exploring the Scientific Rationality of the Phenomenon of “Different Dosage Forms of the Same Prescription” of Chinese Proprietary Medicine Based on Biopharmaceutical Properties of Powder and Pill of Chuanxiong Chatiao Prescription
por: Qu, Zhong-huan, et al.
Publicado: (2022)

Determinants of Growth in Prescription Drug Spending Using 2010–2019 Health Insurance Claims Data
por: Lee, HyeYeong, et al.
Publicado: (2021)

The combination of Chinese and Western Medicine in the management of rheumatoid arthritis: A real-world cohort study across China
por: Zhong, Linda LD., et al.
Publicado: (2022)

Prescription pattern and effectiveness of antihypertensive drugs in patients with aortic dissection who underwent surgery
por: Laio, Kung-Ming, et al.
Publicado: (2023)

Effect of botanical drugs in improving symptoms of hypertensive nephropathy: Analysis of real-world data, retrospective cohort, network, and experimental assessment
por: Huan, Jia-Ming, et al.
Publicado: (2023)

Intrinsic Differences in Immune Checkpoint Inhibitor-Induced Myocarditis: A Retrospective Analysis of Real World Data
por: Lei, Yanna, et al.
Publicado: (2022)

Real-world evidence of autoimmune hepatitis following COVID-19 vaccination: A population-based pharmacovigilance analysis
por: Chen, Congqin, et al.
Publicado: (2023)

Emulated Clinical Trials from Longitudinal Real-World Data Efficiently Identify Candidates for Neurological Disease Modification: Examples from Parkinson’s Disease
por: Laifenfeld, Daphna, et al.
Publicado: (2021)

Hematologic and lymphatic system toxicities associated with immune checkpoint inhibitors: a real-world study
por: Li, Na, et al.
Publicado: (2023)

Real-world study of antiresorptive-related osteonecrosis of jaw based on the US food and drug administration adverse event reporting system database
por: Peng, Jing, et al.
Publicado: (2022)

Drug Prescriptions in the Outpatient Management of COVID-19: Evidence-Based Recommendations Versus Real Practice
por: Belleudi, Valeria, et al.
Publicado: (2022)

Efficacy and Safety of Apatinib in Advanced Hepatocellular Carcinoma: A Multicenter Real World Retrospective Study
por: Zheng, Zhuangzhuang, et al.
Publicado: (2022)

Stevens-Johnson Syndrome Following Vancomycin and Linezolid: A Real-World Analysis of Post-Marketing Surveillance Data
por: Ni, Ming, et al.
Publicado: (2022)

Real-world safety of PCSK9 inhibitors: A pharmacovigilance study based on spontaneous reports in FAERS
por: Feng, Zhen, et al.
Publicado: (2022)

Trends in Antimicrobial Prescription for Inpatients in Changsha, China, 2003 to 2014
por: ZHANG, Yinhua, et al.
Publicado: (2017)

Pharmacoepidemiology Research-Real-World Evidence for Decision Making
por: Bérard, Anick
Publicado: (2021)

Editorial: Real-world experience with CFTR modulator therapy
por: Tümmler, Burkhard, et al.
Publicado: (2023)

Trends in volume-regulated anion channel (VRAC) research: visualization and bibliometric analysis from 2014 to 2022
por: Liu, Tianbao, et al.
Publicado: (2023)

Molecular vasculogenic mimicry–Related signatures predict clinical outcomes and therapeutic responses in bladder cancer: Results from real-world cohorts
por: Zhang, Chunyu, et al.
Publicado: (2023)

Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019
por: Teschke, Rolf
Publicado: (2019)

Real-World Evidence in Prescription Medication Use Among U.S. Adults with Neck Pain
por: Huang, Jin-Feng, et al.
Publicado: (2020)

Risk of Liver Injury Associated with Intravenous Lipid Emulsions: A Prescription Sequence Symmetry Analysis
por: Li, Xiao-xiao, et al.
Publicado: (2021)

Comparison of Adverse Kidney Outcomes With Empagliflozin and Linagliptin Use in Patients With Type 2 Diabetic Patients in a Real-World Setting
por: Lee, Yueh-Ting, et al.
Publicado: (2021)

Editorial: Big Data, Pharmacogenomics and Real-World Research in Pharmacology
por: Wei, James Cheng-Chung, et al.
Publicado: (2020)

Drug utilization research in Peru: Is real-world data available?
por: Rodríguez-Tanta, L. Yesenia, et al.
Publicado: (2023)

Using real-world data to estimate the changing trends in the prevalence and incidence of type 2 diabetes mellitus in Xiamen of China from 2014 to 2019
por: He, Weiwei, et al.
Publicado: (2021)

Using real-world data for supporting regulatory decision making: Comparison of cardiovascular and safety outcomes of an empagliflozin randomized clinical trial versus real-world data
por: Jang, Ha Young, et al.
Publicado: (2022)

Predicting Blood Concentration of Tacrolimus in Patients With Autoimmune Diseases Using Machine Learning Techniques Based on Real-World Evidence
por: Zheng, Ping, et al.
Publicado: (2021)

A glycosylation risk score comprehensively assists the treatment of bladder neoplasm in the real-world cohort, including the tumor microenvironment, molecular and clinical prognosis
por: Liu, Jinhui, et al.
Publicado: (2023)

The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in Italy
por: Otto, Monica Hildegard, et al.
Publicado: (2018)

Impact of Three Safety Interventions Targeting Off-Label Use of Immediate-Release Fentanyl on Prescription Trends: Interrupted Time Series Analysis
por: García-Sempere, Aníbal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dfpv7pou6mk64filfne9otneu5